Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avantea is a premier Italian biotechnology research center specializing in advanced reproductive technologies and animal cloning. Led by Professor Cesare Galli, the laboratory is globally recognized for pioneering achievements, including the creation of the first cloned horse and bull. The company leverages somatic cell nuclear transfer and CRISPR-based genome editing to develop sophisticated large animal models for biomedical applications. A primary focus of their current research is xenotransplantation, where they develop genetically modified pigs to address the global shortage of human organs for transplant. Additionally, Avantea provides commercial assisted reproduction services for high-value livestock and equine breeding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avantea.